A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone

Conclusions:
Further validation of the CRCDS Mini-Sim is warranted to develop this platform for drug safety studies.

Source: Therapeutic Advances in Drug Safety - June 10, 2015 Category: Drugs & Pharmacology Authors: Simen, A. A., Gargano, C., Cha, J.-H., Drexel, M., Bautmans, A., Heirman, I., Laethem, T., Hochadel, T., Gheyle, L., Bleys, K., Beals, C., Stoch, A., Kay, G. G., Struyk, A. Tags: Original Research Source Type: research